CD8A and Alzheimer disease: Mechanistically, MTK treatment increases the number of Tmem119+ microglia and decreases the expression level of AD-associated and lipid droplet accumulation-related genes, which reduces infiltration of CD8+ T cells into the brain parenchyma (Michael et al., 2021).